Clearstead Advisors’s Sensus Healthcare SRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-155
Closed -$617 3723
2026
Q1
$617 Hold
155
﹤0.01% 2098
2025
Q4
$617 Buy
+155
New +$574 ﹤0.01% 2290

Other funds holding SRTS

Clearstead Advisors's SRTS Position: Q2 2026 in Review

Clearstead Advisors sold out of Sensus Healthcare (SRTS) in Q2 2026, closing a stake of 155 shares — an estimated $617 sold.

Clearstead Advisors first reported a position in SRTS in Q4 2025 and held it in 2 quarters. The position peaked at $617 in Q1 2026. 38 funds tracked by Wall St. Rank hold SRTS as of Q2 2026.

  • Clearstead Advisors reported no remaining Sensus Healthcare position as of Q2 2026 after selling out during the quarter.
  • Clearstead Advisors sold 155 Sensus Healthcare shares in Q2 2026, an estimated $617.
  • Clearstead Advisors first reported a position in Sensus Healthcare in Q4 2025 and held it in 2 quarters.
  • Clearstead Advisors's Sensus Healthcare position peaked at $617 in Q1 2026.
  • 38 funds tracked by Wall St. Rank held Sensus Healthcare as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.